Managed Pharmaceutical Markets

The managed care model has seen huge growth in the pharmaceutical industry. It is estimated that in the US, 85% of all prescription drugs are today reimbursed through a managed care plan. In order to ensure preferred and profitable access of drugs in the marketplace, bridging the information and deriving insights across market access, reimbursements, payer relationships, physician influence and physical preferences is critical. All pharmaceutical and medical device companies require analytics, decision supporting systems, and processes to maintain competitive advantages in managing the contract lifecycle while supporting the pricing mechanism (i.e., minimizing revenue leakage) and regulatory requirements needs imposed by various government agencies.

  • Claims Reporting
  • Managed Care Landscape
  • Pricing and Reimbursement Analysis
  • Cost-Benefit Analysis
  • Health Economics and Outcomes Research
  • Compliance and Persistence Studies
0
Connecting
Please wait...
Send a message

Sorry, we aren't online at the moment. Leave a message.

Your name
* Email
* Describe your issue
    Login now

    Need more help? Save time by starting your support request online.

    Your name
    * Email
    * Describe your issue
    We're online!
    Feedback

    Help us help you better! Feel free to leave us any additional feedback.

    How do you rate our support?